Identification and treatment of patients with high cardiovascular risk

Identification and treatment of patients with high cardiovascular risk

Aim. To perform an additional assessment of cardiovascular risk (CVR) levels in patients with low and moderate risk by SCORE scale (European Society of Hypertension/European Society of Cardiology, 2003, 2007), in order to identify the individuals with high CVR; to study the effectiveness of Liptonor...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. V. Sergienko, S. Zh. Urazalina, V. V. Kukharchuk, Yu. A. Karpov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 1970-01-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	cardiovascular risk subclinical atherosclerosis atorvastatin
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2001
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Subclinical atherosclerosis as a risk factor of cardiovascular events
by: S. A. Boytsov, et al.
Published: (2012-06-01)

Alternative risk factors and their importance in assessment of cardiovascular risk in asymptomatic patients
by: N. Yu. Lobanova, et al.
Published: (2020-07-01)

Predicting Cardiovascular Risk Factors for Acute Leukemia Patients by Assessing Subclinical Atherosclerosis and Left Ventricular Function Before Chemotherapy
by: Anda Gabriela Militaru, et al.
Published: (2025-04-01)

Verification of subclinical carotid atherosclerosis as part of risk stratification in overweight and obesity: the role of machine learning in the development of a diagnostic algorithm
by: M. A. Druzhilov, et al.
Published: (2022-08-01)

Subclinical Atherosclerosis Risk Can Be Predicted in Female Patients With Systemic Lupus Erythematosus Using Metabolomic Signatures: An Observational Study
by: Laurel Woodridge, et al.
Published: (2025-04-01)

Biochemical parameters and markers of preclinical pathology of carotid artery wall in patients with different levels of cardiovascular risk by the ESH/ESC scale (2003, 2007)
by: S. Zh. Urazalina, et al.
Published: (1970-01-01)

Subclinical atherosclerosis diagnostics as a component of a modern strategy for cardiovascular risk stratification
by: N. O. Katamadze, et al.
Published: (2012-04-01)

AORTIC PULSE WAVE VELOCITY AS ADDITIONAL PROGNOSTIC CRITERIA IN ABDOMINAL OBESITY
by: M. A. Druzhilov, et al.
Published: (2015-06-01)

Predicting the subclinical carotid atherosclerosis in overweight and obese patients using a machine learning model
by: D. V. Gavrilov, et al.
Published: (2022-05-01)

COMPARATIVE ANALYSIS OF DIAGNOSTIC METHODS FOR SUBCLINICAL VESSELS LESION (UNDER THE COHORT OF EPIDEMIOLOGICAL STUDY ESSE-RF)
by: A. S. Alieva, et al.
Published: (2016-06-01)

RISK PREDICTION FOR SUBCLINICAL ATHEROSCLEROTIC LESION OF BRACHIOCEPHALIC ARTERIES IN OBESE WOMEN
by: N. N. Shenkova, et al.
Published: (2017-05-01)

ROSUVASTATIN - THE MOST POTENT STATIN IN CARDIOVASCULAR DISEASE PREVENTION
by: A. E. Semenova, et al.
Published: (2018-06-01)

ATORVASTATIN — 20 YEARS IN THE STRUGGLE FOR LIFE
by: N. G. Gogolashvili
Published: (2018-03-01)

Atherosclerosis and Insulin Resistance: Is There a Link Between Them?
by: Alina Diduța Brie, et al.
Published: (2025-05-01)

Systematic Coronary Risk Evaluation 2 (SCORE2), arterial stiffness, and subclinical coronary atherosclerosis in a population-based study
by: Susanna Strömberg, et al.
Published: (2025-04-01)

Preclinical markers of carotid atherosclerosis and cardiovascular risk assessed by the ESH/ESC scale (2003, 2007, 2009)
by: S. Sh. Urazalina, et al.
Published: (2011-08-01)

The association of ideal cardiovascular health and its change with subclinical atherosclerosis according to glucose status: A prospective cohort study
by: Xiaojing Jia, et al.
Published: (2024-10-01)

Lipid and pleiotropic effects of atorvastatin in patients with high cardiovascular risk
by: R. S. Karpov, et al.
Published: (2009-08-01)

Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study)
by: S. Yu. Martsevich, et al.
Published: (2019-01-01)

Assessment methods and possibilities of instrumental diagnosis of subclinical atherosclerosis of coronary arteries
by: N. E. Gavrilova, et al.
Published: (2019-12-01)

LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE
by: A. V. Susekov, et al.
Published: (2016-01-01)

Atorvastatin effectiveness in dyslipidemia correction among coronary heart disease and arterial hypertension patients with high risk of cardiovascular complications
by: E. V. Minakov, et al.
Published: (2007-10-01)

Bilirubin and cardiovascular risk
by: O. M. Drapkina, et al.
Published: (2021-10-01)

Prognostic significance of atherosclerosis of one or two vascular systems in patients with high and very high cardiovascular risk
by: V. V. Genkel, et al.
Published: (2021-03-01)

THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015
by: S. A. Smetnev, et al.
Published: (2017-01-01)

Inflammation and Comorbidity. Are There any Chances to Improve the Prognosis in Patients with Extremely High Cardiovascular Risk?
by: M. V. Zykov, et al.
Published: (2021-09-01)

Cardiovascular disturbances and atherosclerosis risk Гасtore in systemic lupus erythematosus
by: T V Popkova, et al.
Published: (2004-08-01)

Association of hypertriglyceridemia with risk factors for cardiovascular and renal complications in individuals with high cardiovascular risk
by: I. T. Murkamilov, et al.
Published: (2023-03-01)

Research status of subclinical hypothyroidism promoting the development and progression of cardiovascular diseases
by: Peijie Wang, et al.
Published: (2025-04-01)

Influence of atorvastatin therapy on biological markers and cardiovascular risk in patients with chronic lymphocytic leukemia in remission
by: B.B. Samura
Published: (2019-02-01)

The prognostic value of various markers of lower limb atherosclerotic lesions in patients with high and very high cardiovascular risk
by: V. V. Genkel, et al.
Published: (2019-06-01)

Carotid intima-media thickness, cardiovascular disease, and risk factors in 29,000 UK Biobank adults
by: Sayan Mitra, et al.
Published: (2025-06-01)

Statin therapy in atherosclerosis prevention: modern strategy and tactics
by: M. G. Bubnova
Published: (2009-06-01)

Lipid-lowering effectiveness of a Russian generic of atorvastatin in patients with various hyperlipidaemia phenotypes
by: P. P. Malyshev, et al.
Published: (2009-12-01)

Randomized study FARVATER: Part II. Atorvastatin effects on endothelial function, vascular wall distensibility and stiffness
by: A. V. Susekov, et al.
Published: (2007-06-01)

Vasoprotective statin effectiveness in patients with carotid atherosclerosis
by: Yu. B. Belousov, et al.
Published: (2007-10-01)

Risk factors of adverse cardiovascular prognosis in patients with peripheral artery disease
by: A. R. Askarov, et al.
Published: (2012-12-01)

Statin therapy in patients with high and very high cardiovascular risk: an optimal approach
by: E. V. Sayutina, et al.
Published: (2020-11-01)

Abdominal aortic diameter as a predictor of peripheral atherosclerosis progression in 40-64-year-old patients with cardiovascular risk factors
by: V. V. Genkel, et al.
Published: (2023-09-01)

Traditional cardiovascular risk factors and atherosclerosis in patients with systemic sclerosis
by: S. S. Shabanova, et al.
Published: (2016-05-01)